MIR548K is a microRNA implicated as a novel oncogene in esophageal squamous cell carcinomas (ESCC), encoded in the 11q13.3–13.4 region, which is frequently amplified in these tumors [PMC5294420]. This microRNA has been associated with enhanced cell proliferation in ESCC cell lines and lies within a region of chromosomal gain that includes other known oncogenes [PMC7137242]. In a South African cohort, MIR548K amplification was observed in 12 out of 51 cases, suggesting its potential role as a key gene [PMC7137242]. Furthermore, MIR548K overexpression has been linked to increased sensitivity to the chemotherapeutic agent PD-0325901 and has been proposed as a target for chemoprevention [PMC5094973]. Depletion of MIR548K results in suppressed cellular growth and mobility, indicating its functional importance in tumor biology [PMC5094973]. Additionally, amplification of MIR548K correlates with poor survival outcomes for ESCC patients and is significantly associated with lymphatic metastasis, highlighting its potential as a prognostic marker and therapeutic target [PMC6103855].
cuuuucucaa c u C A uuac guauug uguuagguugg gcAAAAGUA UUGCGG UUUUGCU u |||||| ||||||||||| ||||||||| |||||| ||||||| u cguagu auaauccaacu cguuuuuau aacgcc aaaacgg u ucgguuaaaa - u u a uaau
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0005882 |
Description | Homo sapiens hsa-miR-548k mature miRNA |
Sequence | 32 - AAAAGUACUUGCGGAUUUUGCU - 53 |
Evidence |
experimental
Illumina [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|